Diabetes mellitus is a chronic disease characterized by high levels of glucose in the blood, which leads to metabolic disorders with severe consequences. Today, there is no cure for diabetes. The current management for diabetes and derived medical conditions, such as hyperglycemia, cardiovascular diseases, or diabetic foot ulcer, includes life style changes and hypoglycemia-based therapy, which do not fully restore euglycemia or the functionality of damaged tissues in patients. This encourages scientists to work outside their boundaries to develop routes that can potentially tackle such metabolic disorders. In this regard, acellular and cellular approaches have represented an alternative for diabetics, although such treatments still face shortcomings related to limited effectiveness and immunogenicity. The advent of biomaterials has brought significant improvements for such approaches, and three-dimensional extracellular matrix analogs, such as hydrogels, have played a key role in this regard. Advanced hydrogels are being developed to monitor high blood glucose levels and release insulin, as well as serve as a therapeutic technology. Herein, the state of the art in advanced hydrogels for improving treatment of diabetes, from laboratory technology to commercial products approved by drug safety regulatory authorities, will be concisely summarized and discussed.
|Original language||American English|
|Journal||Journal of Tissue Engineering and Regenerative Medicine|
|State||E-pub ahead of print - Aug 2019|
Castillo Diaz, L. A., Reyes Martinez, J. E., Ruiz Pacheco, J. A., Flores-Valdéz, M. A., Elsawy, M., & Vallejo Cardona, A. A. (2019). Advanced hydrogels for diabetes treatment. Journal of Tissue Engineering and Regenerative Medicine, 1375-1393. .